Who invested in Shenandoah Therapeutics?
Shenandoah Therapeutics's investors include Samsara BioCapital and Highlight Capital.
United States · Seed startup
Funding summaryUpdated 26 Oct 2026
$20Mraised across 1 round since 2025, from 1 source
Source recordedSEC filing: $21M sold, first sale May 2025
Shenandoah Therapeutics's investors include Samsara BioCapital and Highlight Capital.
Shenandoah Therapeutics has raised $20M across 1 round since 2025.
Shenandoah Therapeutics's most recent round was a Seed of $20M in Jun 2025.
Its most recent round, $20M in Jun 2025, is also its largest on record.
Shenandoah Therapeutics's first round on record, in Jun 2025, was backed by Samsara BioCapital and Highlight Capital.
Shenandoah Therapeutics's latest named round is a Seed, in Jun 2025.
Shenandoah Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.